Abstract:AIM:Many studies reveal an association between the acquired chemoresistant phenotype of cancer cells and tumor-initiating cell-like properties. The aim of this study was to determine the impact of c-Jun N-terminal kinase (JNK) on the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.METHODS:Two well-established human acquired chemoresistant cancer cell lines K562/A02 and KB/VCR, as well as their respective parental counterparts K562 and KB were tested. The expression of relevant mRNAs and proteins was detected using qRT-PCR and Western blotting, respectively. Sphere formation and self-renewal assays were used to study the tumor-initiating cell-like properties. Soft agar and colony formation assays were used to investigate tumorigenic ability.RESULTS:We observed that suppressing JNK activity by its specific small molecule inhibitor SP600125 or by limiting JNK1/2 expression with JNK1/2 shRNA lentiviruses inhibited the expression of pluripotent stem cell markers such as Oct4, Sox2, and Nanog in KB/VCR cells and K562/A02 cells as well as sphere formation and self-renewal abilities of K562/A02 cells. Additionally, inhibition of JNK activity significantly inhibited the in vitro and in vivo tumor-initiating abilities of KB/VCR cells. Furthermore, our data suggest that blocking JNK activity abundantly inhibited the Hedgehog (Hh) pathway activity, as reflected by reduction of Hedgehog (Hh) pathway target genes Gli1 and ptch1 at the mRNA level as well as Gli-luciferase activity.CONCLUSION:JNK maintains the tumor-initiating cell-like properties of acquired chemoresistant K562/A02 and KB/VCR cells potentially through activating the Hedgehog pathway. Thus, disruption of tumor-initiating cell-like properties by targeting JNK may be a new approach to combating acquired chemoresistance.

c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21WAF1/CIP1 in K562 cell

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

The Effect of C-terminal Fragment of JNK2 on the Stability of P53 and Cell Proliferation

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Cooh-Terminal Src Kinase-Mediated C-Jun Phosphorylation Promotes C-Jun Degradation And Inhibits Cell Transformation

Deubiquitylation And Stabilization Of P21 By Usp11 Is Critical For Cell-Cycle Progression And Dna Damage Responses

JNK2 Downregulation Promotes Tumorigenesis and Chemoresistance by Decreasing P53 Stability in Bladder Cancer

Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis.

Stabilization of p27 Kip1 /CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.

Substrate Phosphorylation and Feedback Regulation in Jfk-Promoted P53 Destabilization

p21Waf1/Cip1 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2

Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.

THE CELL SURVIVAL FUNCTION OF JNK

Mekk1 Mediates the Ubiquitination and Degradation of C-Jun in Response to Osmotic Stress

C-Jun N-Terminal Kinase Enhances Mst1-Mediated Pro-Apoptotic Signaling Through Phosphorylation At Serine 82

MSK1 functions as a transcriptional coactivator of p53 in the regulation of p21 gene expression

Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.

p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

JNK is Required for Maintaining the Tumor-Initiating Cell-Like Properties of Acquired Chemoresistant Human Cancer Cells.

Endoplasmic Reticulum Stress-Mediated P62 Downregulation Inhibits Apoptosis Via C-Jun Upregulation.